Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer

Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer

US Patent 11319326 · Granted May 3, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors2025
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors2025
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors2025
Heterocyclic compounds as pad inhibitors2025
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Heterocyclic compounds as pad inhibitors2023
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation2023
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation2022
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation2022
Heterocyclic compounds as PRMT5 inhibitors2022
Heterocyclic compounds as PRMT5 inhibitors2022
Heterocyclic compounds as PRMT5 inhibitors2022